A Common Biomarker Signature for Tolerated Allografts and Self Tissues

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2011.00011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Expression Signature as a Biomarker for Prenatal Diagnosis of Trisomy 21

PLoS ONE
Multidisciplinary
2013English

MRI-based Radiomics Signature Is a Quantitative Prognostic Biomarker for Nasopharyngeal Carcinoma

Scientific Reports
Multidisciplinary
2019English

Identification of a Sixteen-microRNA Signature as Prognostic Biomarker for Stage II and III Colon Cancer

Oncotarget
Oncology
2017English

A Metabolomics-Based Biomarker Signature Discriminates Pancreatic Cancer From Chronic Pancreatitis

Gut
Gastroenterology
2017English

Signature Analysis and Test Scheduling for Self-Testable Circuits

English

A Panel of 13-miRNA Signature as a Potential Biomarker for Predicting Survival in Pancreatic Cancer

Oncotarget
Oncology
2016English

A Targeted Proteomics Approach Reveals a Serum Protein Signature as Diagnostic Biomarker for Resectable Gastric Cancer

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

High Throughput Proteomics Identifies a High-Accuracy 11 Plasma Protein Biomarker Signature for Ovarian Cancer

Communications Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgricultural
2019English

Identifying a Ten-microRNA Signature as a Superior Prognosis Biomarker in Colon Adenocarcinoma

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy